Advertisement

Topics

Tomorrow, FDA will post meeting materials for Tuesday's meeting of the Oncologic Drugs AdComm. #ODAC will review Karyopharm Therapeutics' #selinexor tablets, which is proposed for treatment of certain patients w/ relapsed refractory multiple myeloma. $KPT

16:04 EST 21 Feb 2019 | Odi Bruckman

Tomorrow, FDA will post meeting materials for Tuesday's meeting of the Oncologic Drugs AdComm. will review Karyopharm Therapeutics' tablets, which is proposed for treatment of certain patients w/ relapsed refractory multiple myeloma. https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm631000.htm …

Original Article: Tomorrow, FDA will post meeting materials for Tuesday's meeting of the Oncologic Drugs AdComm. #ODAC will review Karyopharm Therapeutics' #selinexor tablets, which is proposed for treatment of certain patients w/ relapsed refractory multiple myeloma. $KPT

NEXT ARTICLE

More From BioPortfolio on "Tomorrow, FDA will post meeting materials for Tuesday's meeting of the Oncologic Drugs AdComm. #ODAC will review Karyopharm Therapeutics' #selinexor tablets, which is proposed for treatment of certain patients w/ relapsed refractory multiple myeloma. $KPT"

Advertisement
Quick Search
Advertisement
Advertisement